FGFR1 and non-small cell lung carcinoma: Thus, we demonstrated that the enhancement of the FGF2-FGFR1 pathway constitutes a novel mechanism of pemetrexed resistance in NSCLC cells, although the effect of resistance mediated by the FGF2-FGFR1 pathway is not as strong as that by TS.